Discover 779 paid clinical trials in Buffalo, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
for
Weight Management
Location: Niagara Falls, Hamilton, Toronto, Scarborough Village,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07667803
Phase 3, Recruiting
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
for
Atrial Fibrillation (AF)
Location: Saint Catharines, Hamilton, Toronto, Markham, Cambridge,
Sponsor: Anthos Therapeutics, Inc.
Sex: All
Age: 65+
Code: NCT05712200
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
for
Peripheral Arterial Disease, Atherosclerosis of Extremities,
Location: St. Catharines, Hamilton, Oakville, Toronto,
Sponsor: Population Health Research Institute
Sex: All
Age: 18+
Code: NCT04774159
Phase 3, Recruiting
Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease
Location: St. Catharines, Hamilton, Burlington, Toronto,
Sponsor: Hamilton Health Sciences Corporation
Sex: All
Age: 18+
Code: NCT05963698
Recruiting
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
for
Community-acquired Pneumonia, Influenza, COVID-19
Location: Saint Catharines, Hamilton, Toronto, Brantford,
Sponsor: UMC Utrecht
Sex: All
Age: 18+
Code: NCT02735707
Phase 3, Recruiting
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
for
Heart Failure
Location: Stoney Creek, Hamilton, Mississauga, Oakville, Toronto,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06424288
Phase 3, Recruiting
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
for
Heart Failure
Location: Hamilton, Oakville, Toronto, Scarborough Village,
Sponsor: AstraZeneca
Sex: All
Age: 40+
Code: NCT06677060
Phase 3, Recruiting
Chronic Kidney Disease-Education (CKD-EDU)
for
Chronic Kidney Diseases
Location: Brockport NY, Rochester NY, Hornell NY, Canandaigua NY
Sponsor: University of Rochester
Sex: All
Age: 70+
Code: NCT06410144
Recruiting
A Study to Evaluate Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin (CPUO)
for
Chronic Pruritus of Unknown Origin
Location: Hamilton, Boardman OH, The Bronx NY, Quebec,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07700056
Phase 3, Recruiting
Perioperative Anticoagulant Use for Surgery Evaluation -Virtual Visit (PAUSE-Virtual)
for
Atrial Fibrillation (AF)
Location: Hamilton, Detroit MI, Ottawa, Philadelphia PA,
Sponsor: McMaster University
Sex: All
Age: 18 - 70+
Code: NCT06844227
Recruiting
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.
for
Invasive Mold Infections
Location: Hamilton, Ottawa, Ann Arbor MI, Baltimore MD,
Sponsor: Basilea Pharmaceutica
Sex: All
Age: 18+
Code: NCT06925321
Phase 3, Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
for
Asthma
Location: Burlington, Hamilton, Cleveland OH, Windsor, Detroit MI,
Sponsor: AstraZeneca
Sex: All
Age: 5 - 11
Code: NCT06023589
Phase 3, Recruiting
Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
for
Hodgkin Lymphoma
Location: Hamilton, Toronto, Ottawa, New York NY, Saint John,
Sponsor: University College, London
Sex: All
Age: 16 - 69
Code: NCT04685616
Phase 3, Recruiting
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
for
Relapsed or Refractory Multiple Myeloma (RRMM)
Location: Hamilton, Cleveland OH, Pittsburgh PA,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company